Table 2.
Ordinal Regression Analysis on Relative Therapeutic Success Using the Cumulative Link Mixed Model; Baseline Value: Non-Pharmacological Therapy; Overall: Pooling All Data from Vulvodynia, Eczema and Lichen Sclerosus
Variable | OR | Estimate | SE | Z-valuea | p-value |
---|---|---|---|---|---|
Vulvodynia | |||||
Locally invasive | 0.72 | −0.32 | 0.61 | −0.53 | 0.598 |
Topical application | 1.04 | 0.04 | 0.30 | 0.14 | 0.891 |
Oral | 0.19 | −1.65 | 0.72 | −2.30 | 0.021 |
Eczema | |||||
Locally invasive | 1.47 | −0.38 | 1.23 | −0.31 | 0.756 |
Topical application | 1.19 | −0.21 | 1.23 | −0.17 | 0.867 |
Oral | 0.63 | −0.84 | 1.36 | −0.62 | 0.535 |
Lichen sclerosus | |||||
Locally invasive | 1.00 | 0.00 | 1.46 | 0.00 | 1.000 |
Topical application | 7.01 | 1.95 | 0.50 | 3.93 | 0.001 |
Oral | 0.08 | −2.51 | 2.46 | −1.02 | 0.308 |
Overall | |||||
Locally invasive | 0.89 | −0.11 | 0.50 | −0.22 | 0.823 |
Topical application | 0.81 | −0.21 | 1.23 | −0.17 | 0.867 |
Oral | 0.40 | −0.91 | 0.48 | −1.89 | 0.050 |
Note: aWald test.
Abbreviations: OR, Odds ratio; SE, standard error.